Cologne Cohort of Neutropenic Patients (CoCoNut)

Recruiting

• Conditions: Hematological Malignancies; Cancer; Chemotherapy; Immunosuppression; Neutropenia
• Interventions: Drug: Antiinfectives

• Registration Number: NCT01821456
• Lead Sponsor: University Hospital of Cologne

Brief Summary

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

Detailed Description

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Study Timeline

• Study Start: 1995-01
• Status Verified: 2013-03
• Study First Submitted: 2013-03-19
• Study First Submitted QC: 2013-03-26
• Last Update Submitted: 2013-03-26
• Study First Posted: 2013-04-01
• Last Update Posted: 2013-04-01
• Primary Completion: 2050-12
• Study Completion: 2050-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 100000

Inclusion Criteria

• immunosuppressed patients

Exclusion Criteria

• none

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Antiinfectives	Antiinfectives	To analyze the efficacy of antiinfectives at high risk patients

Primary Outcome Measures

Name	Time	Method
Long-term survival of hematology and oncology patients following neutropenia	2 years following last follow-up

Trial Locations

Locations (1)

University Hospital of Cologne; 🇩🇪 Cologne, North Rhine-Westphalia, Germany